Low-Dose Mycophenolate Mofetil for Treatment of Neuromyelitis Optica Spectrum Disorders: A Prospective Multicenter Study in South China

Low-Dose Mycophenolate Mofetil for Treatment of Neuromyelitis Optica Spectrum Disorders: A Prospective Multicenter Study in South China

Objective: To evaluate the efficacy and safety of low-dose mycophenolate mofetil (MMF, 1,000 mg/day) treatment of neuromyelitis optica spectrum disorders (NMOSDs).Methods: This study was a multicenter, open, prospective, follow-up clinical trial. The data include retrospective clinical data from the...

Full description

Bibliographic Details
Main Authors: Qiao Huang, Jingqi Wang, Yifan Zhou, Hui Yang, Zhanhang Wang, Zhenwen Yan, Youming Long, Jia Yin, Huiyu Feng, Caixia Li, Zhengqi Lu, Xueqiang Hu, Wei Qiu
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-09-01
Series:Frontiers in Immunology
Subjects:
neuromyelitis optica spectrum disorders
mycophenolate mofetil
therapy
a prospective study
South China
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.02066/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2018.02066/full

Similar Items